MMGH is proud of announcing the launch of the PEDVAC-iNTS project for the clinical development of a vaccine against invasive Non-Typhoidal Salmonellosis
Post Social Media
MMGH is proud of announcing the launch of the PEDVAC-iNTS project for the clinical development of a vaccine against invasive Non-Typhoidal Salmonellosis
Post Social Media (Facebook)
Our GSK Vaccines Institute for Global Health is dedicated to working with leading partners like CARB-X and the European & Developing Countries Clinical Trials Partnership to develop effective and affordable vaccines that protect vulnerable communities against some of the most prevalent diseases causing high morbidity and mortality in developing countries. #FightAMR
Post Social Media